Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 7/2022

05.08.2022 | Original Article

Converted-hepatopancreatoduodenectomy for an intraoperative positive ductal margin after pancreatoduodenectomy in distal cholangiocarcinoma

verfasst von: Ryusei Yamamoto, Teiichi Sugiura, Ryo Ashida, Katsuhisa Ohgi, Mihoko Yamada, Shimpei Otsuka, Yukiyasu Okamura, Katsuhiko Uesaka

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Pancreatoduodenectomy (PD) is the standard treatment for distal cholangiocarcinoma, and a negative ductal margin (DM0) is indispensable for the long-term survival. When intraoperative frozen sections of ductal margin after PD are positive, converted-hepatopancreatoduodenectomy (C-HPD) is the final option available to gain an additional ductal margin. However, the efficacy of C-HPD remains unclear.

Methods

Patients who underwent PD or C-HPD for distal cholangiocarcinoma between 2002 and 2019 were analyzed. The type of hepatectomy in C-HPD was restricted to left hepatectomy to prevent posthepatectomy liver failure.

Results

Of 203 patients who underwent PD for distal cholangiocarcinoma, 49 patients exhibited intraoperative positive ductal margin (DM1) after PD. Eleven patients underwent C-HPD for intraoperative DM1 after PD, in which intraoperative DM1 with invasive carcinoma (DM1inv) was observed in 3 patients, and intraoperative DM1 with carcinoma in situ (DM1cis) was observed in 8 patients. The median additional ductal margin yielded by C-HPD was 9 mm (interquartile range 7–13 mm). C-HPD eradicated intraoperative DM1inv in 3 patients, with 2 patients showing DM0 and 1 patient showing DM1cis. Regarding 8 patients who underwent C-HPD for intraoperative DM1cis, 4 patients had DM0, but the others had DM1cis. C-HPD was associated with a high complication rate, but no mortality was observed. The median survival time of patients who underwent C-HPD was 48.8 months.

Conclusion

C-HPD was able to safely eradicate intraoperative DM1inv after PD. However, the length of the resected bile duct according to C-HPD may not be sufficient to remove intraoperative DM1cis after PD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (2010) International Union Against Cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley-Liss, New York Sobin LH, Gospodarowicz MK, Wittekind C (2010) International Union Against Cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley-Liss, New York
2.
Zurück zum Zitat DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762CrossRefPubMedCentralPubMed DeOliveira ML, Cunningham SC, Cameron JL et al (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Komaya K, Ebata T, Shirai K et al (2017) Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg 104:426–433CrossRefPubMed Komaya K, Ebata T, Shirai K et al (2017) Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg 104:426–433CrossRefPubMed
4.
Zurück zum Zitat Igami T, Nagino M, Oda K et al (2009) Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249:296–302CrossRefPubMed Igami T, Nagino M, Oda K et al (2009) Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg 249:296–302CrossRefPubMed
5.
Zurück zum Zitat Toyoda Y, Ebata T, Mizuno T et al (2019) Cholangiographic tumor classification for simple patient selection prior to hepatopancreatoduodenectomy for cholangiocarcinoma. Ann Surg Oncol 26:2971–2979CrossRefPubMed Toyoda Y, Ebata T, Mizuno T et al (2019) Cholangiographic tumor classification for simple patient selection prior to hepatopancreatoduodenectomy for cholangiocarcinoma. Ann Surg Oncol 26:2971–2979CrossRefPubMed
6.
Zurück zum Zitat Nakanishi Y, Zen Y, Kawakami H et al (2008) Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol 21:807–816CrossRefPubMed Nakanishi Y, Zen Y, Kawakami H et al (2008) Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases. Mod Pathol 21:807–816CrossRefPubMed
7.
Zurück zum Zitat Konishi M, Iwasaki M, Ochiai A et al (2010) Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg 97:1363–1368CrossRefPubMed Konishi M, Iwasaki M, Ochiai A et al (2010) Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg 97:1363–1368CrossRefPubMed
8.
Zurück zum Zitat Park Y, Hwang DW, Kim JH et al (2019) Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection. J Hepatobiliary Pancreat Sci 26:169–178CrossRefPubMed Park Y, Hwang DW, Kim JH et al (2019) Prognostic comparison of the longitudinal margin status in distal bile duct cancer: R0 on first bile duct resection versus R0 after additional resection. J Hepatobiliary Pancreat Sci 26:169–178CrossRefPubMed
9.
Zurück zum Zitat Ebata T, Yokoyama Y, Igami T et al (2012) Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg 256:297–305CrossRefPubMed Ebata T, Yokoyama Y, Igami T et al (2012) Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg 256:297–305CrossRefPubMed
10.
Zurück zum Zitat Aoki T, Sakamoto Y, Kohno Y et al (2018) Hepatopancreaticoduodenectomy for biliary cancer: strategies for near-zero operative mortality and acceptable long-term outcome. Ann Surg 267:332–337CrossRefPubMed Aoki T, Sakamoto Y, Kohno Y et al (2018) Hepatopancreaticoduodenectomy for biliary cancer: strategies for near-zero operative mortality and acceptable long-term outcome. Ann Surg 267:332–337CrossRefPubMed
11.
Zurück zum Zitat Yoshimi F, Asato Y, Amemiya R et al (2001) Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer. Hepatogastroenterology 48:994–998PubMed Yoshimi F, Asato Y, Amemiya R et al (2001) Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer. Hepatogastroenterology 48:994–998PubMed
12.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M et al (2010) Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg 34:2662–2670CrossRefPubMed Kaneoka Y, Yamaguchi A, Isogai M et al (2010) Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg 34:2662–2670CrossRefPubMed
13.
Zurück zum Zitat Vandenbroucke JP, von Elm E, Altman DG et al (2014) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg 12:1500–1524CrossRefPubMed Vandenbroucke JP, von Elm E, Altman DG et al (2014) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg 12:1500–1524CrossRefPubMed
14.
Zurück zum Zitat Ito K, Sakamoto Y, Isayama H et al (2018) The impact of MDCT and endoscopic transpapillary mapping biopsy to predict longitudinal spread of extrahepatic cholangiocarcinoma. J Gastrointest Surg 22:1528–1537CrossRefPubMed Ito K, Sakamoto Y, Isayama H et al (2018) The impact of MDCT and endoscopic transpapillary mapping biopsy to predict longitudinal spread of extrahepatic cholangiocarcinoma. J Gastrointest Surg 22:1528–1537CrossRefPubMed
15.
Zurück zum Zitat Yamamoto R, Sugiura T, Okamura Y et al (2021) Utility of remnant liver volume for predicting posthepatectomy liver failure after hepatectomy with extrahepatic bile duct resection. BJS Open 5:zraa049CrossRefPubMedCentralPubMed Yamamoto R, Sugiura T, Okamura Y et al (2021) Utility of remnant liver volume for predicting posthepatectomy liver failure after hepatectomy with extrahepatic bile duct resection. BJS Open 5:zraa049CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Yamamoto Y, Ashida R, Ohgi K et al (2018) Combined antrectomy reduces the incidence of delayed gastric emptying after pancreatoduodenectomy. Dig Surg 35:121–130CrossRefPubMed Yamamoto Y, Ashida R, Ohgi K et al (2018) Combined antrectomy reduces the incidence of delayed gastric emptying after pancreatoduodenectomy. Dig Surg 35:121–130CrossRefPubMed
17.
Zurück zum Zitat Sugiura T, Okamura Y, Ito T et al (2019) Left hepatectomy with combined resection and reconstruction of right hepatic artery for bismuth type I and II perihilar cholangiocarcinoma. World J Surg 43:894–901CrossRefPubMed Sugiura T, Okamura Y, Ito T et al (2019) Left hepatectomy with combined resection and reconstruction of right hepatic artery for bismuth type I and II perihilar cholangiocarcinoma. World J Surg 43:894–901CrossRefPubMed
18.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedCentralPubMed Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724CrossRefPubMed Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724CrossRefPubMed
20.
Zurück zum Zitat Bassi C, Marchegiani G, Dervenis C et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161:584–591CrossRefPubMed Bassi C, Marchegiani G, Dervenis C et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161:584–591CrossRefPubMed
21.
Zurück zum Zitat Nitta N, Ohgi K, Sugiura T et al (2021) Prognostic impact of paraaortic lymph node metastasis in extrahepatic cholangiocarcinoma. World J Surg 45:581–589CrossRefPubMed Nitta N, Ohgi K, Sugiura T et al (2021) Prognostic impact of paraaortic lymph node metastasis in extrahepatic cholangiocarcinoma. World J Surg 45:581–589CrossRefPubMed
22.
Zurück zum Zitat Ebata T, Hirano S, Konishi M et al (2018) Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J Surg 105:192–202CrossRefPubMed Ebata T, Hirano S, Konishi M et al (2018) Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J Surg 105:192–202CrossRefPubMed
23.
Zurück zum Zitat Nakachi K, Konishi M, Ikeda M et al (2018) A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). Jpn J Clin Oncol 48:392–395CrossRefPubMed Nakachi K, Konishi M, Ikeda M et al (2018) A randomized phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). Jpn J Clin Oncol 48:392–395CrossRefPubMed
24.
Zurück zum Zitat Sugiura T, Uesaka K, Okamura Y et al (2020) Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma. Ann Gastroenterol Surg 4:455–463CrossRefPubMedCentralPubMed Sugiura T, Uesaka K, Okamura Y et al (2020) Adjuvant chemoradiotherapy for positive hepatic ductal margin on cholangiocarcinoma. Ann Gastroenterol Surg 4:455–463CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Hirose T, Igami T, Ebata T et al (2015) Surgical and radiological studies on the length of the hepatic ducts. World J Surg 39:2983–2989CrossRefPubMed Hirose T, Igami T, Ebata T et al (2015) Surgical and radiological studies on the length of the hepatic ducts. World J Surg 39:2983–2989CrossRefPubMed
26.
Zurück zum Zitat Ebata T, Watanabe H, Ajioka Y et al (2002) Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89:1260–1267CrossRefPubMed Ebata T, Watanabe H, Ajioka Y et al (2002) Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 89:1260–1267CrossRefPubMed
27.
Zurück zum Zitat Ke Q, Wang B, Lin N et al (2019) Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis. World J Surg Oncol 17:211CrossRefPubMedCentralPubMed Ke Q, Wang B, Lin N et al (2019) Does high-grade dysplasia/carcinoma in situ of the biliary duct margin affect the prognosis of extrahepatic cholangiocarcinoma? A meta-analysis. World J Surg Oncol 17:211CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Tsukahara T, Ebata T, Shimoyama Y et al (2017) Residual carcinoma in situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinomas. Ann Surg 266:126–132CrossRefPubMed Tsukahara T, Ebata T, Shimoyama Y et al (2017) Residual carcinoma in situ at the ductal stump has a negative survival effect: an analysis of early-stage cholangiocarcinomas. Ann Surg 266:126–132CrossRefPubMed
29.
Zurück zum Zitat Yasukawa K, Shimizu A, Motoyama H et al (2021) Impact of remnant carcinoma in situ at the ductal stump on long-term outcomes in patients with distal cholangiocarcinoma. World J Surg 45:291–301CrossRefPubMed Yasukawa K, Shimizu A, Motoyama H et al (2021) Impact of remnant carcinoma in situ at the ductal stump on long-term outcomes in patients with distal cholangiocarcinoma. World J Surg 45:291–301CrossRefPubMed
30.
Zurück zum Zitat Welch JC, Gleeson EM, Karachristos A et al (2020) Hepatopancreatoduodenectomy in North America: are the outcomes acceptable? HPB (Oxford) 22:360–367CrossRefPubMed Welch JC, Gleeson EM, Karachristos A et al (2020) Hepatopancreatoduodenectomy in North America: are the outcomes acceptable? HPB (Oxford) 22:360–367CrossRefPubMed
31.
Zurück zum Zitat D’Souza MA, Valdimarsson VT, Campagnaro T et al (2020) Hepatopancreatoduodenectomy - a controversial treatment for bile duct and gallbladder cancer from a European perspective. HPB (Oxford) 22:1339–1348CrossRefPubMed D’Souza MA, Valdimarsson VT, Campagnaro T et al (2020) Hepatopancreatoduodenectomy - a controversial treatment for bile duct and gallbladder cancer from a European perspective. HPB (Oxford) 22:1339–1348CrossRefPubMed
32.
Zurück zum Zitat Endo I, Hirahara N, Miyata H et al (2021) Mortality, morbidity, and failure to rescue in hepatopancreatoduodenectomy: an analysis of patients registered in the National Clinical Database in Japan. J Hepatobiliary Pancreat Sci 28:305–316CrossRefPubMed Endo I, Hirahara N, Miyata H et al (2021) Mortality, morbidity, and failure to rescue in hepatopancreatoduodenectomy: an analysis of patients registered in the National Clinical Database in Japan. J Hepatobiliary Pancreat Sci 28:305–316CrossRefPubMed
33.
Zurück zum Zitat Yokoyama Y, Ebata T, Igami T et al (2016) The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg 40:1440–1447CrossRefPubMed Yokoyama Y, Ebata T, Igami T et al (2016) The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg 40:1440–1447CrossRefPubMed
34.
Zurück zum Zitat Primrose JN, Fox RP, Palmer DH et al (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20:663–673CrossRefPubMed Primrose JN, Fox RP, Palmer DH et al (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20:663–673CrossRefPubMed
35.
Zurück zum Zitat Bridgewater J, Fletcher P, Palmer DH et al (2022) Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study. J Clin Oncol 22:Jco102568 Bridgewater J, Fletcher P, Palmer DH et al (2022) Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study. J Clin Oncol 22:Jco102568
Metadaten
Titel
Converted-hepatopancreatoduodenectomy for an intraoperative positive ductal margin after pancreatoduodenectomy in distal cholangiocarcinoma
verfasst von
Ryusei Yamamoto
Teiichi Sugiura
Ryo Ashida
Katsuhisa Ohgi
Mihoko Yamada
Shimpei Otsuka
Yukiyasu Okamura
Katsuhiko Uesaka
Publikationsdatum
05.08.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 7/2022
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-022-02598-2

Weitere Artikel der Ausgabe 7/2022

Langenbeck's Archives of Surgery 7/2022 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.